What is the 1366302-52-4?

1366302-52-4 is , while it's Molecular Formula is C44H62N6O17. Used in Neurobiological Research: 1366302-52-4 is used as a research tool for investigating its potential therapeutic effects on neurological disorders, particularly Alzheimer’s disease. It is employed to understand the role of GSK3β inhibition in the treatment and management of neurodegenerative conditions. Used in Pharmaceutical Development: In the pharmaceutical industry, 1366302-52-4 is used as a lead compound in the development of new drugs targeting GSK3β. This is aimed at creating novel therapeutics for the treatment of various neurological disorders, with a focus on Alzheimer’s disease and other related conditions. Used in Clinical Trials: 1366302-52-4 is utilized in clinical trials to assess its safety, efficacy, and potential side effects when used as a treatment for neurological disorders. These trials are essential for determining the viability of AZD1080 as a therapeutic agent and for guiding its future use in medical practice.

What is the CAS number for 1366302-52-4?

The CAS number of 1366302-52-4 is 1366302-52-4.

What is 1366302-52-4 (1366302-52-4) used for?

1366302-52-4, also known as AZD1080, is a chemical compound that functions as a potent and selective inhibitor of glycogen synthase kinase-3 beta (GSK3β). It is primarily used in neurobiological research to explore its potential therapeutic effects on neurological disorders such as Alzheimer’s disease. The detailed chemical properties or effects on human health and the environment are not fully known, as it is mainly used in a laboratory setting or under clinical trials. Due to potential risks or effects that are yet to be fully discovered and assessed, it is generally not intended for public or uncontrolled use.

What is the 1366302-52-4?

1366302-52-4 is , while it's Molecular Formula is C44H62N6O17. Used in Neurobiological Research: 1366302-52-4 is used as a research tool for investigating its potential therapeutic effects on neurological disorders, particularly Alzheimer’s disease. It is employed to understand the role of GSK3β inhibition in the treatment and management of neurodegenerative conditions. Used in Pharmaceutical Development: In the pharmaceutical industry, 1366302-52-4 is used as a lead compound in the development of new drugs targeting GSK3β. This is aimed at creating novel therapeutics for the treatment of various neurological disorders, with a focus on Alzheimer’s disease and other related conditions. Used in Clinical Trials: 1366302-52-4 is utilized in clinical trials to assess its safety, efficacy, and potential side effects when used as a treatment for neurological disorders. These trials are essential for determining the viability of AZD1080 as a therapeutic agent and for guiding its future use in medical practice.

What is the CAS number for 1366302-52-4?

The CAS number of 1366302-52-4 is 1366302-52-4.

What is 1366302-52-4 (1366302-52-4) used for?

1366302-52-4, also known as AZD1080, is a chemical compound that functions as a potent and selective inhibitor of glycogen synthase kinase-3 beta (GSK3β). It is primarily used in neurobiological research to explore its potential therapeutic effects on neurological disorders such as Alzheimer’s disease. The detailed chemical properties or effects on human health and the environment are not fully known, as it is mainly used in a laboratory setting or under clinical trials. Due to potential risks or effects that are yet to be fully discovered and assessed, it is generally not intended for public or uncontrolled use.

Manufacturers supply cost-effective and customizable PSMA11 1366302-52-4

CAS#1366302-52-4
NamePSMA11
For reserach use only and not for human use!

Product Details

MF： C44H62N6O17